Product Information

GABAPENTIN 800 MG TABLET is a generic product labeled by Mullan Pharmaceutical Inc., priced at $0.0860 per EA under NDC 83301000201. Its NADAC has been published 66 times since Aug 13, 2025.

FDA first approved this application on Oct 26, 2017. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

GABAPENTIN 800 MG TABLET

Gabapentin
$0.0860per EA

Strength

800 mg/1

NDC

83301000201

Classification

Generic

Dosage Form

TABLET, COATED

Route

ORAL

Effective Date

10/21/2026

Active Ingredients

GABAPENTIN

Approval Type

Generic (ANDA)

FDA Application

ANDA207057

FDA Approved

10/26/2017

TE Code

AB1

On Market Since

1/1/2024

Pharmacological Classes

Decreased Central Nervous System Disorganized Electrical Activity

Price Statistics

The NADAC for GABAPENTIN 800 MG TABLET has been published 66 times since Aug 13, 2025, and over the history we have for it it has declined 15.4%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0860 per EA
All-time high$0.1029 (Sep 10, 2025)
All-time low$0.0860 (Oct 21, 2026)
52-week high$0.1015
52-week low$0.0860
Median price$0.0987
Average price$0.0972
Largest weekly change-4.0% (Aug 19, 2026)
Weeks tracked66
Tracking sinceAug 13, 2025

Price History

1W

0.0%

1M

-2.6%

3M

-8.3%

6M

-12.2%

1Y

-15.4%

3Y

N/A

5Y

N/A

All

-15.4%

Generic Alternatives

The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GABAPENTIN 800 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 800 MG TABLET, manufactured by Mullan Pharmaceutical Inc., is $0.0860 per EA (NDC 83301000201), effective Nov 11, 2026.

How has the price of GABAPENTIN 800 MG TABLET changed over time?

Over the history we have for it, the NADAC for GABAPENTIN 800 MG TABLET has declined 15.4%. It has been tracked across 66 weekly CMS publications since Aug 13, 2025.

What are the highest and lowest recorded NADAC prices for GABAPENTIN 800 MG TABLET?

Since Aug 13, 2025, the NADAC for GABAPENTIN 800 MG TABLET has ranged from a low of $0.0860 (Oct 21, 2026) to a high of $0.1029 (Sep 10, 2025), with a median of $0.0987 per EA.

Are there cheaper alternatives to GABAPENTIN 800 MG TABLET?

21 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GABAPENTIN 800 MG TABLET in a comparable dosage form, but none are currently priced below it.

Who manufactures GABAPENTIN 800 MG TABLET?

GABAPENTIN 800 MG TABLET (NDC 83301000201) is labeled by Mullan Pharmaceutical Inc., and CMS classifies it as a generic product.